Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00853632 · ClinicalTrials.gov registry record · NA
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 329
- Enrollment target
NCT00853632 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 329 participants.
The verdict
NCT00853632, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 329 participants
- Enrollment target
Study Summary
The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards® PERIMOUNT Magna Mitral Valves in patients undergoing mitral valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.
Interventions
- DEVICE CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2007-08 |
| Est. Completion | 2024-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00853632
The ClinicalTrials.gov registry entry for NCT00853632 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES is the first listed.
NCT00853632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00853632 about?
NCT00853632 is a clinical study titled "Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol". The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards® PERIMOUNT Magna Mitral Valves in patients undergoing mitral valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.
What is the current status of trial NCT00853632?
This trial is currently completed. It is a NA study. The enrollment target is 329 participants. The study started on 2007-08. Estimated completion is 2024-03-06.
What interventions are being tested in trial NCT00853632?
The interventions under investigation include: CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES (DEVICE).
Who is sponsoring clinical trial NCT00853632?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.